Trial Profile
International, Multicenter, Double-blind, Placebo-Controlled, Randomized Phase I/II Trial of Desmoteplase in the Indication of Acute Ischemic Stroke
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 Apr 2008
Price :
$35
*
At a glance
- Drugs Desmoteplase (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Acronyms DEDAS
- Sponsors PAION
- 12 Mar 2008 Added sponsor, from clinicaltrials.gov record.
- 18 Apr 2006 New trial record.